ClinConnect ClinConnect Logo
Search / Trial NCT05301114

Social Risk Factors and Discrimination in Cancer Survivorship

Launched by MEDSTAR HEALTH RESEARCH INSTITUTE · Mar 18, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Health Equity Community Health Worker Social Support Community Based Organizations Social Determinants Of Health Breast Cancer Prostate Cancer Health Disparities

ClinConnect Summary

This clinical trial is focused on understanding and improving the health and well-being of Black cancer survivors, specifically those who have had breast or prostate cancer. The study aims to identify social factors that may affect their recovery and access to care, and to connect them with community resources that can provide support. Researchers will explore how having Community Health Workers—individuals who help guide patients through the healthcare system—can enhance the quality of life and social connections for these survivors. Additionally, the trial will assess how training healthcare staff in anti-racism practices might reduce experiences of discrimination among patients.

To be eligible for the trial, participants need to be Black or African American and have been diagnosed with either stage I-III breast or prostate cancer, with their treatment completed, or stage IV cancer diagnosed about six months ago. Participants can expect to engage with community resources and provide feedback on their experiences, which will help improve healthcare for future cancer survivors. This study is currently recruiting individuals aged 65 to 74, and it welcomes all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of stage I-III breast or prostate cancer and completed curative treatment (surgery, radiation, chemotherapy) or finalized treatment plan (e.g. watch and wait); OR Stage IV breast or prostate cancer approximately 6 months from diagnosis
  • Black or African American race

About Medstar Health Research Institute

MedStar Health Research Institute (MHRI) is a leading clinical research organization affiliated with MedStar Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a robust portfolio of clinical trials across various therapeutic areas, MHRI collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of new treatments and interventions. The institute is committed to maintaining the highest standards of ethical conduct and scientific rigor while fostering a culture of inquiry that enhances the health and well-being of the communities it serves.

Locations

Washington, District Of Columbia, United States

Patients applied

0 patients applied

Trial Officials

Hannah Arem, PhD

Principal Investigator

Medstar Health Research Institute

Mandi Pratt-Chapman, PhD

Principal Investigator

George Washington University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials